| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | 1 | 1 | — | — | — | — | 2 | — | — | 2 | 1 |
| total | individual payouts | |
|---|---|---|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 2,215.00 | 2,048.00 | 2,036.00 | 1,986.00 |
| Receivables | 19,025.00 | 17,592.00 | 17,837.00 | 17,391.00 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 21,240.00 | 19,640.00 | 19,873.00 | 19,377.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 73,996.00 | 68,989.00 | 69,890.00 | 69,241.00 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 73,996.00 | 68,989.00 | 69,890.00 | 69,241.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1,777.00 | 1,901.00 | — | — |
—
|
| ’25 | 1,786.00 | 1,796.00 | 1,935.00 | 1,784.00 |
7,301.00
|
| ’24 | 1,864.00 | 1,769.00 | 1,880.00 | 1,782.00 |
7,295.00
|
| ’23 | 1,854.00 | 1,892.00 | 1,831.00 | 1,911.00 |
7,488.00
|
| ’22 | 1,893.00 | 1,887.00 | 1,848.00 | 1,867.00 |
7,495.00
|
| ’21 | 1,985.00 | 2,041.00 | 2,070.00 | 1,726.00 |
7,822.00
|
| ’20 | 1,809.00 | 2,003.00 | 2,318.00 | 2,154.00 |
8,284.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 91.00 | 52.00 | — | — |
—
|
| ’25 | 34.00 | 6.00 | 87.00 | 200.00 |
327.00
|
| ’24 | (107.00) | 7.00 | 161.00 | 27.00 |
88.00
|
| ’23 | 17.00 | 258.00 | 175.00 | 147.00 |
597.00
|
| ’22 | (92.00) | 429.00 | 308.00 | 404.00 |
1,049.00
|
| ’21 | (247.00) | 476.00 | 61.00 | 147.00 |
437.00
|
| ’20 | 680.00 | 619.00 | 153.00 | 508.00 |
1,960.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 91.00 | 52.00 | — | — |
—
|
| ’25 | 34.00 | 6.00 | 87.00 | 223.00 |
350.00
|
| ’24 | (107.00) | 7.00 | 161.00 | 27.00 |
88.00
|
| ’23 | 17.00 | 258.00 | 175.00 | 147.00 |
597.00
|
| ’22 | (92.00) | 429.00 | 308.00 | 404.00 |
1,049.00
|
| ’21 | (247.00) | 476.00 | 61.00 | 147.00 |
437.00
|
| ’20 | 680.00 | 619.00 | 153.00 | 508.00 |
1,960.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.12 | 0.12 | — | — |
—
|
| ’25 | 0.13 | 0.12 | 0.28 | 0.00 |
0.54
|
| ’24 | 0.31 | 0.17 | 0.20 | 0.00 |
0.68
|
| ’23 | 0.12 | 0.29 | 0.06 | (0.47) |
0.16
|
| ’22 | 0.29 | 0.35 | 0.20 | 0.35 |
1.19
|
| ’21 | 0.37 | 0.47 | 0.61 | 0.32 |
1.76
|
| ’20 | (0.13) | (0.86) | 0.82 | 0.52 |
0.35
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 3.43 | 4.51 | 5.67 | 5.99 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 5.37 | 6.93 | 7.90 | 9.28 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,500 | 2,700 | 2,960 | 3,100 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.00 | 2.77 | 2.46 | 2.36 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,495.00 | 7,488.00 | 7,295.00 | 7,301.00 | — | — | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 35.86% | 29.41% | 28.46% | 28.68% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,365.00 | 303.00 | 595.00 | 433.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.21% | 4.05% | 8.16% | 5.93% | ‡‡‡ | ‡‡‡ | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,046.00 | 199.00 | 427.00 | 350.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 172.00 | 158.00 | 130.00 | 93.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.86 | 15.97 | 16.81 | 17.85 | ‡‡‡ | ‡‡‡ | — |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 1.21 | 0.16 | 0.69 | 0.54 | ‡‡‡‡ | ‡‡‡‡ | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.08 | 1.27 | 0.20 | 0.80 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.06 | ‡‡‡ | ‡‡‡ | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.08 | 1.27 | 0.20 | 0.86 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.63 | 17.78 | 21.62 | 23.88 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 504.40 | 468.80 | 433.90 | 409.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Shares
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 4.32 | 667.00 | 10.28 | 16.72 | ‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.35 | 0.42 | 0.42 | 0.51 | ‡‡‡ | ‡‡‡ | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.31 | 0.38 | 0.32 | 0.38 | ‡‡‡ | ‡‡‡ | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.36 | 0.36 | 0.37 | 0.46 | — | — | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.54 | 4.55 | 30.93 | 10.36 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,049.00 | 597.00 | 88.00 | 327.00 | ‡‡‡ | ‡‡‡ | — |
Op' Cash Flow
|
| — | — | — | — | — | — | — | — | — | 23.00 | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,049.00 | 597.00 | 88.00 | 350.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (52,062.00) | (52,756.00) | (49,349.00) | (50,017.00) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,611.00 | 1,584.00 | 1,518.00 | 1,513.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (188.00) | (631.00) | (530.00) | (523.00) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8,386.00 | 8,335.00 | 9,381.00 | 9,767.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.97% | 0.08% | 0.34% | 0.25% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.21% | 3.42% | 5.01% | 3.64% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.43% | 0.91% | 3.38% | 2.33% | — | — | — |
ROE
|
Genworth Financial (GNW) is at a thrilling inflection point, having transformed through the 2021 Enact spin-off that slashed debt by 55% since 2016, turned net debt into a $530M cash position, and ignited profitability surges—with EBT margins tripling to 8.2% and ROE turning positive. Revenue stability around $7B annually, coupled with 15% headcount cuts and 13% share shrinkage, showcases operational efficiency and resilience amid housing headwinds, positioning GNW as an undervalued powerhouse in mortgage insurance ready to capitalize on rate normalization and market recovery.
Trading at dirt-cheap multiples—0.32x book value, 0.42x sales, and 10x forward P/E—GNW boasts analyst consensus for 12% upside, fueled by AI-driven underwriting innovations, potential margin expansion to 10%+, and housing volume rebound projecting EPS growth to $0.43 by 2026. This lean, cash-rich disruptor in legacy financials signals explosive compounding potential for growth seekers—dive into the full analysis for the charts, projections, and catalysts that make it a must-watch.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.